(A) Agilent Technologies - Ratings and Ratios
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US00846U1016
A: Spectrometers, Chromatography, Instruments, Software, Reagents, Pumps
Agilent Technologies Inc (NYSE:A) stands as a pivotal player in the life sciences, diagnostics, and applied chemical markets, offering tailored solutions that drive scientific and industrial progress. Their operations are divided into three core segments, each addressing distinct needs in the scientific community.
The Life Sciences and Applied Markets segment is a powerhouse of analytical instrumentation, providing tools like liquid chromatography systems, mass spectrometry, and atomic absorption instruments. These technologies are essential for researchers and industries seeking precise chemical analysis, underscoring Agilents role in advancing pharmaceutical development and environmental monitoring.
The Diagnostics and Genomics segment delves into cutting-edge areas such as genomics and companion diagnostics. By offering nucleic acid manufacturing and biomolecular analysis, Agilent supports critical research in personalized medicine, positioning itself as a key enabler of medical advancements.
Agilent CrossLab ensures laboratories run smoothly with a comprehensive range of supplies and services. From chromatography columns to instrument maintenance, this segment highlights Agilents commitment to supporting the entire lifecycle of scientific equipment, enhancing efficiency and compliance for their clients.
With a market capitalization of over $41 billion, Agilents financials reveal a P/E ratio of 32.78 and a forward P/E of 25.97, indicating robust growth prospects. Their strategic focus on innovation and global market reach makes them a compelling consideration for investors and fund managers eyeing the life sciences sector.
Headquartered in Santa Clara, California, Agilents global presence and diverse product portfolio underscore their importance in supporting scientific advancements. Their role in enabling research and industrial applications positions them as a cornerstone in the scientific community, offering both stability and growth potential in a dynamic market landscape.
Web URL: https://www.agilent.com
Additional Sources for A Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
A Stock Overview
| Market Cap in USD | 36,123m |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| GiC Sub-Industry | Life Sciences Tools & Services |
| IPO / Inception | 1999-11-18 |
A Stock Ratings
| Growth 5y | 33.2% |
| Fundamental | 40.4% |
| Dividend | 52.4% |
| Rel. Strength Industry | -18.4 |
| Analysts | 3.74/5 |
| Fair Price Momentum | 112.72 USD |
| Fair Price DCF | 107.53 USD |
A Dividends
| Dividend Yield 12m | 0.74% |
| Yield on Cost 5y | 1.43% |
| Annual Growth 5y | 12.10% |
| Payout Consistency | 66.9% |
A Growth Ratios
| Growth Correlation 3m | -27% |
| Growth Correlation 12m | -13.7% |
| Growth Correlation 5y | 41.2% |
| CAGR 5y | 12.60% |
| CAGR/Max DD 5y | 0.29 |
| Sharpe Ratio 12m | -0.36 |
| Alpha | -26.24 |
| Beta | 0.81 |
| Volatility | 28.99% |
| Current Volume | 2106.6k |
| Average Volume 20d | 2079.9k |
As of March 12, 2025, the stock is trading at USD 121.03 with a total of 2,106,622 shares traded.
Over the past week, the price has changed by -1.65%, over one month by -14.62%, over three months by -14.12% and over the past year by -17.26%.
Partly, yes. Based on ValueRay Fundamental Analyses, Agilent Technologies (NYSE:A) is currently (March 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 40.39 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of A as of March 2025 is 112.72. This means that A is currently overvalued and has a potential downside of -6.87%.
Agilent Technologies has received a consensus analysts rating of 3.74. Therefor, it is recommend to hold A.
- Strong Buy: 6
- Buy: 3
- Hold: 9
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, A Agilent Technologies will be worth about 126.3 in March 2026. The stock is currently trading at 121.03. This means that the stock has a potential upside of +4.38%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 151.6 | 25.2% |
| Analysts Target Price | 150.1 | 24.1% |
| ValueRay Target Price | 126.3 | 4.4% |